Safety study of HDM1002 tablets on heart rhythm in healthy adults
Treatments studied
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Weigh at least 50 kg (about 110 lbs) with a BMI between 19.0 and 28.0
- Be in generally good health with no major medical conditions affecting your heart, lungs, liver, kidneys, or nervous system
- Have no personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN2)
- Not be pregnant or breastfeeding
- Not have had recent major surgery, blood donation, or significant blood loss in the past 3–4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new drug called XY0206 affects the heart's electrical activity (QTc interval). Healthy participants take either XY0206, a placebo, or a control drug to compare effects. It helps ensure the drug is safe for the heart before testing in patients.
This trial tests a medicine called HDM1002 in people who have different levels of liver function. It aims to see how the liver affects the drug and if it is safe.
This trial studies how a new medicine, HDM1005, may change the way the body absorbs or processes some common medications like metformin, atorvastatin, warfarin, and digoxin. It may help doctors understand if HDM1005 can be taken safely with other drugs.
This study tests how a new drug called HDM1002 interacts with common diabetes medications (metformin, empagliflozin) and other drugs like warfarin and valsartan. If you are a generally healthy adult (age 18-45) with a higher BMI, this trial helps ensure the new drug is safe when taken with other medicines.
This study tests a new oral drug to see how it affects the heart's rhythm in healthy adults. It helps make sure the drug is safe before it's tested in patients.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Hear when a new Healthy Adult Subject trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.